Exendin-4 protected against critical limb ischemia in obese mice

American Journal of Translational Research

Volumn 7, Issue 3, 2015, Pages 445-459

  Sheu, Jiunn Jye ^a   Chang, Meng Wei ^a   Wallace, Christopher Glenn ^b   Chiang, Hsin Ju ^a   Sung, Pei Hsun ^a   Tsai, Tzu Hsien ^a   Chung, Sheng Ying ^a   Chen, Yung Lung ^a   Chua, Sarah ^a   Chang, Hsueh Wen ^c   Sun, Cheuk Kwan ^d   Lee, Fan Yen ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Apoptosis; Critical limb ischemia; Exendin 4; Obesity

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; CHEMOKINE RECEPTOR CXCR4; CYTOCHROME C; EXENDIN 4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; SMAD PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANEMOMETRY; ANGIOGENESIS; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD FLOW; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HYPOXIA; IMMUNOFLUORESCENCE TEST; MALE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALIA; MUS;

EID: 84930002398     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. World Health Organization: Obesity and overweight. 2013. http://www.who.int/mediacentre/factsheets/fs311/en/.
2. Finkelstein EA, Khavjou OA, Thompson H, Tro-gdon JG, Pan L, Sherry B, Dietz W. Obesity and severe obesity forecasts through 2030. Am J Prev Med 2012; 42: 563-570.
3. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
4. Fakhouri TH, Ogden CL, Carroll MD, Kit BK, Flegal KM Prevalence of obesity among older adults in the United States, 2007-2010. NCHS Data Brief 2012; 1-8.
5. Wright SM, Aronne LJ. Causes of obesity. Ab-dom Imaging 2012; 37: 730-732.
6. Friedman JM. Obesity in the new millennium. Nature 2000; 404: 632-634.
7. Hanson C, Rutten EP, Wouters EF, Rennard S. Influence of diet and obesity on COPD development and outcomes. Int J Chron Obstruct Pulmon Dis 2014; 9: 723.
8. Nigro E, Scudiero O, Monaco ML, Palmieri A, Mazzarella G, Costagliola C, Bianco A, Daniele A. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int 2014; 2014: 658913.
9. Iantorno M, Campia U, Di Daniele N, Nistico S, Forleo GB, Cardillo C, Tesauro M. Obesity, inflammation and endothelial dysfunction. J Biol Regul Homeost Agents 2014; 28: 169-176.
10. Tsai TH, Chai HT, Sun CK, Yen CH, Leu S, Chen YL, Chung SY, Ko SF, Chang HW, Wu CJ, Yip HK. Obesity suppresses circulating level and function of endothelial progenitor cells and heart function. J Transl Med 2012; 10: 137.
11. Chen YL, Chang CL, Sun CK, Wu CJ, Tsai TH, Chung SY, Chua S, Yeh KH, Leu S, Sheu JJ. Impact of obesity control on circulating level of endothelial progenitor cells and angiogenesis in response to ischemic stimulation. J Transl Med 2012; 10: 86.
12. Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Sillje HH. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol 2010; 30: 1407-1414.
13. Shimoda M, Kanda Y, Hamamoto S, Tawara-moto K, Hashiramoto M, Matsuki M, Kaku K. The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes. Diabetologia 2011; 54: 1098-1108.
14. Hattori Y, Jojima T, Tomizawa A, Satoh H, Ha-ttori S, Kasai K, Hayashi T. A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells. Dia-betologia 2010; 53: 2256-2263.
15. Kim S, Moon M, Park S. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson’s disease. J Endocrinol 2009; 202: 431-439.
16. Chen YT, Tsai TH, Yang CC, Sun CK, Chang LT, Chen HH, Chang CL, Sung PH, Zhen YY, Leu S, Chang HW, Chen YL, Yip HK. Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med 2013; 11: 270.
17. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis HR, Jr. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997; 99: 385-390.
18. Sun CK ZY, Lu HI, Sung PH, Chang LT, Tsai TH, Sheu JJ, Chen YL, Sarah Chua, Chang HW, Chen YL, Lee FY, Yip HK. Reducing TRPC1 expression through liposome-mediated siRNA delivery markedly attenuates hypoxia-induced pulmonary arterial hypertension in a murine model. Stem Cells Int 2014; 2014: 316214.
19. Yip HK, Sun CK, Tsai TH, Sheu JJ, Kao YH, Lin YC, Shiue YL, Chen YL, Chai HT, Chua S, Ko SF, Leu S. Tissue plasminogen activator enhances mobilization of endothelial progenitor cells and angiogenesis in murine limb ischemia. Int J Cardiol 2013; 168: 226-236.
20. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 2008; 39: 69-74.
21. Muller-Ehmsen J, Braun D, Schneider T, Pfister R, Worm N, Wielckens K, Scheid C, Frommolt P, Flesch M. Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. Eur Heart J 2008; 29: 1560-1568.
22. Huang CY, Shih CM, Tsao NW, Lin YW, Huang PH, Wu SC, Lee AW, Kao YT, Chang NC, Nakagami H, Morishita R, Ou KL, Hou WC, Lin CY, Shyu KG, Lin FY. Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells. Br J Pharmacol 2012; 167: 1506-1519.
23. Chua S, Sheu JJ, Chen YL, Chang LT, Sun CK, Leu S, Sung HC, Tsai TH, Chung SY, Yeh KH, Cho CL, Kao YH, Yip HK. Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis-evaluations in vitro and in the rat critical limb ischemia model. Cyto-therapy 2013; 15: 1148-1163.
24. Leu S, Lu HI, Sun CK, Sheu JJ, Chen YL, Tsai TH, Yeh KH, Chai HT, Chua S, Tsai CY, Chang HW, Lee FY, Yip HK. Retention of endothelial progenitor cells in bone marrow in a murine model of endogenous tissue plasminogen activator (tPA) deficiency in response to critical limb ischemia. Int J Cardiol 2014; 170: 394-405.
25. Sheu JJ, Lin KC, Tsai CY, Tsai TH, Leu S, Yen CH, Chen YL, Chang HW, Sun CK, Chua S, Yang JL, Yip HK. Combination of cilostazol and clopidogrel attenuates rat critical limb ischemia. J Transl Med 2012; 10: 164.